Agnieszka Czapko
Agnieszka serves as the Head of the Regulatory and Start-up Department at Pure Clinical. She oversees feasibility assessments, clinical site recruitment and cooperation, as well as coordination of clinical studies evaluating the performance of IVD medical devices. She supports research teams throughout the entire study process — from the preparation of documentation compliant with ICH-GCP, ISO 20916:2019, IVDR 2017/746, and FDA requirements, to obtaining ethical and regulatory approvals. She holds a degree in Biotechnology and Environmental Protection from the University of Warsaw, specializing in microbiology. Her professional background includes work as a microbiology specialist in pharmaceutical companies, where she co-authored and reviewed scientific publications. Agnieszka is currently pursuing postgraduate studies in Clinical Trial Management and Monitoring at Kozminski University in Warsaw.
Agnieszka Czapko
Education (2)
Uniwersytet Warszawski
Master's degree, Environmental Protection
paź 2002 – wrz 2007
Uniwersytet Warszawski
Master's degree, Biotechnology / Microbiology
X 2003 – IX 2008
Work Experience (7)
Pure Clinical
Senior Clinical Affairs Specialist
III 2023 - obecnie
Clinical Affairs Specialist
II 2022 - currently
Uniwersytet Warszawski
PHD Student
X 2018 – II 2022
ZF Polpharma SA
Quality Control Specialist
IX 2013 – VI 2015
Publications (3)
Antibiotics and Antibiotic Resistance Genes in Animal Manure – Consequences of Its Application in Agriculture. Front. Microbiol., 29 March 2021 | https://doi.org/10.3389/fmicb.2021.610656
The impact of environmental contamination with antibiotics on levels of resistance in soil bacteria. J Environ Qual. Sep-Oct 2010;39(5):1679-87. doi: 10.2134/jeq2009.0499.